BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6473171)

  • 1. Glucagon-37 (oxyntomodulin) and glucagon-29 (pancreatic glucagon) in human bowel: analysis by HPLC and radioreceptorassay.
    Munck A; Kervran A; Marie JC; Bataille D; Rosselin G
    Peptides; 1984; 5(3):553-61. PubMed ID: 6473171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bioactive "enteroglucagon" (oxyntomodulin): evidence for a C-terminal extension of the glucagon molecule].
    Bataille D; Tatemoto K; Coudray AM; Rosselin G; Mutt V
    C R Seances Acad Sci III; 1981 Oct; 293(6):323-8. PubMed ID: 6797684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
    Kervran A; Blache P; Bataille D
    Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities.
    Bataille D; Gespach C; Tatemoto K; Marie JC; Coudray AM; Rosselin G; Mutt V
    Peptides; 1981; 2 Suppl 2():41-4. PubMed ID: 6283496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Isolation of the peptide.
    Bataille D; Coudray AM; Carlqvist M; Rosselin G; Mutt V
    FEBS Lett; 1982 Sep; 146(1):73-8. PubMed ID: 7140976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
    Blache P; Kervran A; Bataille D
    Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide.
    Bataille D; Tatemoto K; Gespach C; Jörnvall H; Rosselin G; Mutt V
    FEBS Lett; 1982 Sep; 146(1):79-86. PubMed ID: 7140977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
    Blache P; Kervran A; Martinez J; Bataille D
    Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.
    Ghatei MA; Uttenthal LO; Bryant MG; Christofides ND; Moody AJ; Bloom SR
    Endocrinology; 1983 Mar; 112(3):917-23. PubMed ID: 6822217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-related peptides in the human gastrointestinal mucosa.
    Baldissera FG; Holst JJ
    Diabetologia; 1984 Mar; 26(3):223-8. PubMed ID: 6546922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and sequence of rat oxyntomodulin.
    Collie NL; Walsh JH; Wong HC; Shively JE; Davis MT; Lee TD; Reeve JR
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9362-6. PubMed ID: 7937770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of the gut hormones in the primate intestinal tract.
    Bryant MG; Bloom SR
    Gut; 1979 Aug; 20(8):653-9. PubMed ID: 114457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biological significance of "enteroglucagon." Present status.
    Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
    Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Enterolglucagon': a specific effect on gastric glands isolated from the rat fundus. Evidence for an "oxyntomodulin' action.
    Bataille D; Gespach C; Coudray AM; Rosselin G
    Biosci Rep; 1981 Feb; 1(2):151-5. PubMed ID: 6271273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oxyntomodulin (glucagon-37) and glucagon on exocrine pancreatic secretion in the conscious rat.
    Biedzinski TM; Bataille D; Devaux MA; Sarles H
    Peptides; 1987; 8(6):967-72. PubMed ID: 3441447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxyntomodulin (glicentin-(33-69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs.
    Baldissera FG; Holst JJ; Knuhtsen S; Hilsted L; Nielsen OV
    Regul Pept; 1988 May; 21(1-2):151-66. PubMed ID: 2839871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic and intestinal processing of proglucagon in man.
    Orskov C; Holst JJ; Poulsen SS; Kirkegaard P
    Diabetologia; 1987 Nov; 30(11):874-81. PubMed ID: 3446554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Demonstration of a specific receptor site for glucagon-37 (oxyntomodulin/bioactive enteroglucagon) in rat oxyntic glands].
    Depigny C; Lupo B; Kervran A; Bataille D
    C R Acad Sci III; 1984; 299(16):677-80. PubMed ID: 6097350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of peptide hormones from the pancreas of the bullfrog (Rana catesbeiana). Amino acid sequences of pancreatic polypeptide, oxyntomodulin, and two glucagon-like peptides.
    Pollock HG; Hamilton JW; Rouse JB; Ebner KE; Rawitch AB
    J Biol Chem; 1988 Jul; 263(20):9746-51. PubMed ID: 3260236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-phase peptide synthesis of human(Nle-27)-oxyntomodulin. Preliminary evaluation of its biological activities.
    Audousset-Puech MP; Dufour M; Kervran A; Jarrousse C; Castro B; Bataille D; Martinez J
    FEBS Lett; 1986 May; 200(1):181-5. PubMed ID: 3009226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.